Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Getty

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Brain Research|February 24, 2009
Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosisJill M Weimer, Jared W Benedict, Amanda L Getty, et al.
The Journal of Biological Chemistry|October 15, 2010
Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leadsMichael J Caulfield, Vadim Y Dudkin, Elizabeth A Ottinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2017
In Vivo Imaging of the Programmed Death Ligand 1 by <sup>18</sup>F PETDinko E González Trotter, Xiangjun Meng, Paul McQuade, et al.
Journal of Medicinal Chemistry|April 16, 2004
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymeraseAnne B Eldrup, Charles R Allerson, C Frank Bennett, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic propertiesDavid B Olsen, Anne B Eldrup, Linda Bartholomew, et al.
The Journal of Biological Chemistry|September 11, 2003
Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitroGiovanni Migliaccio, Joanne E Tomassini, Steven S Carroll, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Identification of potent inhibitors of the sortilin-progranulin interactionShawn J Stachel, Anthony T Ginnetti, Scott A Johnson, et al.
Viruses|July 27, 2024
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Alvarez, Gregory C Adam, John A Howe, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Brain Research|February 24, 2009
Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosisJill M Weimer, Jared W Benedict, Amanda L Getty, et al.
The Journal of Biological Chemistry|October 15, 2010
Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leadsMichael J Caulfield, Vadim Y Dudkin, Elizabeth A Ottinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2017
In Vivo Imaging of the Programmed Death Ligand 1 by <sup>18</sup>F PETDinko E González Trotter, Xiangjun Meng, Paul McQuade, et al.
Journal of Medicinal Chemistry|April 16, 2004
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymeraseAnne B Eldrup, Charles R Allerson, C Frank Bennett, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic propertiesDavid B Olsen, Anne B Eldrup, Linda Bartholomew, et al.
The Journal of Biological Chemistry|September 11, 2003
Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitroGiovanni Migliaccio, Joanne E Tomassini, Steven S Carroll, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Identification of potent inhibitors of the sortilin-progranulin interactionShawn J Stachel, Anthony T Ginnetti, Scott A Johnson, et al.
Viruses|July 27, 2024
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Alvarez, Gregory C Adam, John A Howe, et al.
Pageof 3